C
78.83
0.54 (0.69%)
| Previous Close | 78.29 |
| Open | 78.44 |
| Volume | 3,063,598 |
| Avg. Volume (3M) | 3,679,941 |
| Market Cap | 41,466,945,536 |
| Price / Earnings (TTM) | 14.85 |
| Price / Earnings (Forward) | 9.68 |
| Price / Sales | 0.250 |
| Price / Book | 1.39 |
| 52 Weeks Range | |
| Earnings Date | 25 Oct 2024 |
| Profit Margin | 1.96% |
| Operating Margin (TTM) | 4.66% |
| Diluted EPS (TTM) | 5.31 |
| Quarterly Revenue Growth (YOY) | 3.60% |
| Quarterly Earnings Growth (YOY) | 8.30% |
| Total Debt/Equity (MRQ) | 64.20% |
| Current Ratio (MRQ) | 1.17 |
| Operating Cash Flow (TTM) | 2.96 B |
| Levered Free Cash Flow (TTM) | 1.97 B |
| Return on Assets (TTM) | 3.78% |
| Return on Equity (TTM) | 10.59% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bullish |
| Healthcare Plans (Global) | Bullish | Bullish | |
| Stock | Centene Corporation | Bullish | Bullish |
Stockmoo Score
0.9
| Analyst Consensus | 1.5 |
| Insider Activity | 1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.90 |
|
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.27% |
| % Held by Institutions | 100.98% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Jun 2024 | 12,135,044 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 97.00 (Barclays, 23.05%) | Buy |
| Median | 90.00 (14.17%) | |
| Low | 69.00 (Jefferies, -12.47%) | Hold |
| Average | 88.29 (12.00%) | |
| Total | 5 Buy, 2 Hold | |
| Avg. Price @ Call | 73.79 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Cantor Fitzgerald | 01 Oct 2024 | 90.00 (14.17%) | Buy | 73.94 |
| 20 Sep 2024 | 90.00 (14.17%) | Buy | 75.61 | |
| Wells Fargo | 13 Sep 2024 | 91.00 (15.44%) | Buy | 75.35 |
| 22 Jul 2024 | 81.00 (2.75%) | Buy | 66.14 | |
| Barclays | 05 Sep 2024 | 97.00 (23.05%) | Buy | 72.66 |
| 22 Aug 2024 | 98.00 (24.32%) | Buy | 78.23 | |
| Deutsche Bank | 02 Aug 2024 | 87.00 (10.36%) | Hold | 78.09 |
| TD Cowen | 31 Jul 2024 | 89.00 (12.90%) | Buy | 76.92 |
| 24 Jul 2024 | 80.00 (1.48%) | Buy | 66.12 | |
| Oppenheimer | 29 Jul 2024 | 95.00 (20.51%) | Buy | 73.48 |
| Jefferies | 24 Jul 2024 | 69.00 (-12.47%) | Hold | 66.12 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |